Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-08 Sale |
2020-06-09 4:17 pm |
Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director |
4,567 | $12.1 | $55,261 | 57,933 (Direct) |
View |
| 2020-06-08 Sale |
2020-06-09 4:17 pm |
Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director |
4,567 | $12.08 | $55,169 | 58,964 (Direct) |
View |
| 2020-06-08 Sale |
2020-06-09 4:17 pm |
Akebia Therapeutics Inc. | AKBA | GOWEN MAXINE Director |
4,567 | $12.05 | $55,032 | 44,233 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-02 4:34 pm |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO |
6,426 | $11.58 | $74,413 | 73,574 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-05 Option Award |
2020-06-09 4:17 pm |
2021-06-05 2030-06-05 |
Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director |
33,800 | $0 | 57,933 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:17 pm |
2021-06-05 2030-06-05 |
Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director |
33,800 | $0 | 58,964 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:17 pm |
2021-06-05 2030-06-05 |
Akebia Therapeutics Inc. | AKBA | GOWEN MAXINE Director |
33,800 | $0 | 44,233 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:17 pm |
2021-06-05 2030-06-05 |
Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director |
33,800 | $0 | 58,729 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:17 pm |
2021-06-05 2030-06-05 |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
33,800 | $0 | 54,986 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:17 pm |
2021-06-05 2030-06-05 |
Akebia Therapeutics Inc. | AKBA | Enyedy Mark J Director |
33,800 | $0 | 51,243 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:16 pm |
2021-06-05 2030-06-05 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
33,800 | $0 | 97,500 (Direct) |
View |